Article Details
Retrieved on: 2022-12-29 11:08:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Minerva Neurosciences Announces Update on its New Drug Application (NDA) for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here